Exploring the Potential of Calebin‐A in Targeting Obesity‐Related Genes and Pathways
Journal of Cellular and Molecular Medicine · 2026-06 · 30 (11)
DOI: 10.1111/jcmm.71244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 12.06.2026. Verfasst von Ali Mahmoudi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Sciences, Faculty of Medicine, Abadan University of Medical Sciences, Abadan, Iran. Hauptthemen laut MEDLINE: Obesity, Signal Transduction, Gene Expression Regulation. Die Arbeit nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Abadan University of Medical Sciences.
Abstract (Originalsprache)
Obesity is a global health crisis affecting millions, associated with metabolic disorders such as type 2 diabetes and cardiovascular disease. Calebin‐A, a bioactive compound derived from Curcuma species, has shown promise in managing obesity and its complications. This study utilized bioinformatics tools to explore the molecular mechanisms of Calebin‐A in obesity. Transcriptomic data from obese and normal omental adipose tissue (GSE286454) were analysed, identifying 317 differentially expressed genes (DEGs). Functional enrichment analysis indicated a notable engagement of lysosomal activity, immune response, cell migration, axon guidance and apoptosis pathways. A STRING‐based protein–protein interaction network revealed nine hub genes through a composite centrality score. Among these, CTSB, CTSZ, CTSA, GRN and TUBB exhibited upregulation and were prioritized for subsequent analysis. External validation (GSE59034; 16 obese vs. 16 controls) corroborated the consistent upregulation of CTSB, CTSZ, GRN and CTSA. Target prediction analysis identified 443 potential targets for Calebin‐A, with pathway‐level overlap suggesting a convergence on immune, lysosomal and cytoskeletal processes. Molecular docking studies indicated favourable binding affinities (−5.2 to −7.1 kcal/mol), with CTSZ demonstrating the most robust interaction. A 100 ns molecular dynamics simulation validated structural stability and indicated favourable binding free energy (MM‐PBSA Δ G ≈ −110 kJ/mol). Results suggest that Calebin‐A targets genes and proteins involved in energy balance and inflammation, offering insights into its anti‐obesity potential. These findings provide a foundation for experimental validation and therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Basic Medical Sciences, Faculty of Medicine, Abadan University of Medical Sciences, Abadan, Iran.
- Department of Molecular Biology and Genetics, Canakkale Onsekiz Mart University, Canakkale, Turkey.
- Next-Generation Translational Nanomedicine Laboratory, Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar, Madhya Pradesh, India.
- University Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, India.
- Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
- Centre for Research Impact and Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab, India.
ORCID-Profile: Prashant Kesharwani, Amirhossein Sahebkar
Förderung
- Abadan University of Medical Sciences
Zitieren
APA
Mahmoudi, A., Saeedi-Boroujeni, A., Karav, S., Kesharwani, P., & Sahebkar, A. (2026). Exploring the Potential of Calebin‐A in Targeting Obesity‐Related Genes and Pathways. Journal of Cellular and Molecular Medicine, 30(11). https://doi.org/10.1111/jcmm.71244
Vancouver
Mahmoudi A, Saeedi-Boroujeni A, Karav S, Kesharwani P, Sahebkar A. Exploring the Potential of Calebin‐A in Targeting Obesity‐Related Genes and Pathways. Journal of Cellular and Molecular Medicine. 2026;30(11). doi:10.1111/jcmm.71244
BibTeX
@article{Mahmoudi2026,
author = {Mahmoudi, Ali and Saeedi-Boroujeni, Ali and Karav, Sercan and Kesharwani, Prashant and Sahebkar, Amirhossein},
title = {Exploring the Potential of Calebin‐A in Targeting Obesity‐Related Genes and Pathways},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
volume = {30},
number = {11},
doi = {10.1111/jcmm.71244}
}
EUVIMED